Literature DB >> 10730110

Effect of beer consumption on plasma magnesium: randomized comparison with mineral water.

S Gorinstein1, M Zemser, I Libman, S Trakhtenberg, A Caspi.   

Abstract

Moderate consumption of ethanol lowers mortality from coronary artery disease, and one of the possible mechanisms is an antiarrhythmic action. We therefore investigated the effect of a small daily dose of beer on plasma electrolytes. 52 men who seldom drank alcohol, clinically stable more than one year after coronary bypass surgery, were randomized to drink either 330 mL beer (containing about 20 g ethanol) or mineral water with similar potassium, magnesium, calcium and sodium content daily for 30 days. Plasma electrolytes and liver function indices, and also heart rate, blood pressure and weight, were measured before and after the trial period. The only significant before-and-after difference was in the group consuming beer, whose plasma magnesium rose from 0.89 (SD 0.01) to 0.98 (SD 0.02) mmol/L (P < 0.0025). This level of beer consumption did no obvious harm to liver function and its possibly beneficial effect on plasma magnesium deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10730110      PMCID: PMC1296981          DOI: 10.1177/014107689809101205

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  13 in total

1.  Moderate beer consumption and the blood coagulation in patients with coronary artery disease.

Authors:  S Gorinstein; M Zemser; I Lichman; A Berebi; A Kleipfish; I Libman; S Trakhtenberg; A Caspi
Journal:  J Intern Med       Date:  1997-01       Impact factor: 8.989

Review 2.  [Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?].

Authors:  R Haberl
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

3.  Moderate beer consumption and positive biochemical changes in patients with coronary atherosclerosis.

Authors:  S Gorinstein; M Zemser; M Berliner; R Goldstein; I Libman; S Trakhtenberg; A Caspi
Journal:  J Intern Med       Date:  1997-09       Impact factor: 8.989

4.  Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators.

Authors:  M Zehender; T Meinertz; T Faber; A Caspary; A Jeron; K Bremm; H Just
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

Review 5.  Magnesium and cardiac arrhythmias.

Authors:  L T Iseri
Journal:  Magnesium       Date:  1986

6.  The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study).

Authors:  H Tsuji; F J Venditti; J C Evans; M G Larson; D Levy
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

7.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

8.  An experimental model examining the role of magnesium in the therapy of acute myocardial infarction.

Authors:  J Leor; R A Kloner
Journal:  Am J Cardiol       Date:  1995-06-15       Impact factor: 2.778

9.  Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

10.  Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.

Authors:  K K Teo; S Yusuf; R Collins; P H Held; R Peto
Journal:  BMJ       Date:  1991-12-14
View more
  1 in total

1.  Validation of a Newly Developed Food Frequency Questionnaire to Assess Dietary Intakes of Magnesium.

Authors:  Deeptha Sukumar; Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Tammy Ng; Alicia Lamoureux
Journal:  Nutrients       Date:  2019-11-15       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.